Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
MEDANTANSE
NHNSE
KIMSNSE
LALPATHLABNSE
VIJAYANSE
AGARWALEYENSE
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 35% | 27% | 22% |
| - | - | 12% | 52% |
| - | - | - | 9% |
| 5% | 14% | 8% | 9% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
MEDANTA
NH
KIMS
LALPATHLAB
VIJAYA
AGARWALEYE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,888.5 | ₹130273 Cr | 62.35 | 40.39 | 207.67 | ₹1942 Cr |
| 1,046 | ₹102446 Cr | 70.32 | 3.31 | 19.84 | ₹1442 Cr |
| 742.5 | ₹100021 Cr | 112.09 | 1.96 | 11.95 | ₹892 Cr |
| 877.35 | ₹67267 Cr | 64.19 | 3.53 | 20.1 | ₹1042 Cr |
| 768.65 | ₹66295 Cr | 208.03 | 0.31 | 6.76 | ₹388 Cr |
| 1,506.2 | ₹40209 Cr | 72.3 | 5.91 | 29.85 | ₹556 Cr |
| 1,877.7 | ₹39270 Cr | 48.12 | 10.14 | 65.36 | ₹806 Cr |
| 802 | ₹33529 Cr | 164.12 | 1.04 | 12.74 | ₹241 Cr |
| 1,961.3 | ₹32271 Cr | 59.55 | 10.11 | 42.51 | ₹505 Cr |
| 1,526.5 | ₹16149 Cr | 86.13 | 5.16 | 27.53 | ₹173 Cr |
| 503.75 | ₹15713 Cr | 105.91 | 1.43 | 13.88 | ₹133 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹32 Cr | ₹32 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| ₹12 Cr | ₹10 Cr | ₹6 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 |
| ₹1982 Cr | ₹1825 Cr | ₹1324 Cr | ₹620 Cr | ₹206 Cr | ₹177 Cr | ₹242 Cr |
| ₹1982 Cr | ₹1825 Cr | ₹1324 Cr | ₹620 Cr | ₹206 Cr | ₹177 Cr | ₹242 Cr |
| ₹2025 Cr | ₹1867 Cr | ₹1339 Cr | ₹630 Cr | ₹212 Cr | ₹184 Cr | ₹249 Cr |
| ₹94 Cr | ₹60 Cr | ₹40 Cr | ₹30 Cr | ₹21 Cr | ₹14 Cr | ₹18 Cr |
| ₹133 Cr | ₹157 Cr | ₹310 Cr | ₹306 Cr | ₹254 Cr | ₹168 Cr | ₹145 Cr |
| -₹26 Cr | -₹25 Cr | -₹35 Cr | -₹53 Cr | -₹13 Cr | -₹13 Cr | -₹11 Cr |
| ₹1203 Cr | ₹1084 Cr | ₹648 Cr | ₹546 Cr | ₹324 Cr | ₹265 Cr | ₹188 Cr |
| ₹24 Cr | ₹18 Cr | ₹14 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr |
| ₹1334 Cr | ₹1235 Cr | ₹937 Cr | ₹809 Cr | ₹572 Cr | ₹425 Cr | ₹327 Cr |
| — | — | — | — | — | — | — |
| ₹149 Cr | ₹127 Cr | ₹133 Cr | ₹101 Cr | ₹89 Cr | ₹75 Cr | ₹64 Cr |
| ₹280 Cr | ₹329 Cr | ₹233 Cr | ₹189 Cr | ₹95 Cr | ₹58 Cr | ₹64 Cr |
| ₹0 | ₹0 | ₹15 Cr | ₹5 Cr | ₹10 Cr | ₹10 Cr | ₹12 Cr |
| ₹32 Cr | ₹22 Cr | ₹19 Cr | ₹7 Cr | ₹12 Cr | ₹8 Cr | ₹6 Cr |
| ₹461 Cr | ₹478 Cr | ₹400 Cr | ₹301 Cr | ₹206 Cr | ₹150 Cr | ₹146 Cr |
| ₹3915 Cr | ₹3640 Cr | ₹2716 Cr | ₹1770 Cr | ₹1012 Cr | ₹774 Cr | ₹740 Cr |
| ₹68 Cr | ₹73 Cr | ₹19 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹8 Cr |
| ₹157 Cr | ₹247 Cr | ₹388 Cr | ₹356 Cr | ₹290 Cr | ₹185 Cr | ₹162 Cr |
| — | — | — | — | — | — | — |
| ₹3764 Cr | ₹3397 Cr | ₹2399 Cr | ₹1794 Cr | ₹1082 Cr | ₹854 Cr | ₹738 Cr |
| ₹891 Cr | ₹871 Cr | ₹653 Cr | ₹501 Cr | ₹381 Cr | ₹279 Cr | ₹188 Cr |
| ₹3 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2870 Cr | ₹2523 Cr | ₹1746 Cr | ₹1293 Cr | ₹701 Cr | ₹575 Cr | ₹551 Cr |
| ₹234 Cr | ₹144 Cr | ₹114 Cr | ₹98 Cr | ₹28 Cr | ₹11 Cr | ₹8 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹70 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹70 L |
| ₹108 Cr | ₹106 Cr | ₹93 Cr | ₹67 Cr | ₹55 Cr | ₹34 Cr | ₹35 Cr |
| ₹120 Cr | ₹69 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹3342 Cr | ₹2851 Cr | ₹1958 Cr | ₹1460 Cr | ₹785 Cr | ₹619 Cr | ₹594 Cr |
| — | — | — | — | — | — | — |
| ₹152 Cr | ₹264 Cr | ₹471 Cr | ₹34 Cr | ₹0 | ₹0 | ₹0 |
| ₹94 Cr | ₹80 Cr | ₹52 Cr | ₹36 Cr | ₹33 Cr | ₹28 Cr | ₹33 Cr |
| ₹161 Cr | ₹124 Cr | ₹97 Cr | ₹76 Cr | ₹57 Cr | ₹47 Cr | ₹52 Cr |
| ₹129 Cr | ₹251 Cr | ₹125 Cr | ₹149 Cr | ₹117 Cr | ₹65 Cr | ₹44 Cr |
| ₹13 Cr | ₹51 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹23 Cr | ₹19 Cr | ₹9 Cr | ₹9 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr |
| ₹573 Cr | ₹789 Cr | ₹759 Cr | ₹310 Cr | ₹227 Cr | ₹154 Cr | ₹146 Cr |
| ₹111 Cr | ₹311 Cr | ₹359 Cr | ₹9 Cr | ₹21 Cr | ₹4 Cr | -₹6 L |
| ₹3915 Cr | ₹3640 Cr | ₹2716 Cr | ₹1770 Cr | ₹1012 Cr | ₹774 Cr | ₹740 Cr |
| ₹64 | ₹59 | ₹1,429 | ₹792 | ₹310 | ₹269 | ₹363 |
| ₹64 | ₹59 | ₹48 | ₹26 | ₹10 | ₹9 | ₹12 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| ₹249 Cr | ₹160 Cr | ₹141 Cr | ₹84 Cr | ₹57 Cr | -₹48 Cr | -₹11 Cr |
| ₹373 Cr | ₹331 Cr | ₹233 Cr | ₹197 Cr | ₹138 Cr | ₹145 Cr | ₹139 Cr |
| -₹48 Cr | -₹98 Cr | ₹5 Cr | -₹13 Cr | -₹15 Cr | ₹10 Cr | -₹9 Cr |
| ₹574 Cr | ₹394 Cr | ₹378 Cr | ₹268 Cr | ₹180 Cr | ₹107 Cr | ₹120 Cr |
| ₹519 Cr | ₹357 Cr | ₹346 Cr | ₹233 Cr | ₹164 Cr | ₹99 Cr | ₹103 Cr |
| -₹308 Cr | -₹750 Cr | -₹914 Cr | -₹509 Cr | -₹155 Cr | -₹37 Cr | -₹80 Cr |
| -₹220 Cr | ₹382 Cr | ₹553 Cr | ₹303 Cr | ₹35 Cr | -₹37 Cr | -₹73 Cr |
| -₹10 Cr | -₹11 Cr | -₹15 Cr | ₹27 Cr | ₹44 Cr | ₹25 Cr | -₹50 Cr |
| ₹100 Cr | ₹112 Cr | ₹127 Cr | ₹100 Cr | ₹55 Cr | ₹39 Cr | ₹94 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹9 Cr | -₹6 Cr |
| ₹91 Cr | ₹100 Cr | ₹112 Cr | ₹127 Cr | ₹100 Cr | ₹55 Cr | ₹39 Cr |
Fundamental Ratios
Consolidated
Standalone
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
49.09Neutral
STOCH %K
40.20Neutral
MACD Level(12,26)
-2.00Sell
Ultimate Oscillator
60.17Buy
Aroon Oscillator
28.00Sell
BOP
0.65Buy
CCI
-50.78Neutral
Williams %R
-59.80Neutral
Momentum
-9.35Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 moving averages
EMA 9
500.01Buy
SMA 9
499.59Buy
EMA 21
503.17Sell
SMA 21
505.76Sell
EMA 50
499.29Buy
SMA 50
502.76Sell
EMA 200
474.39Buy
SMA 200
472.36Buy
WMA 20
503.51Sell
Pivot
Pivot
Classic
Resistance 5
548.37
Resistance 4
534.47
Resistance 3
520.57
Resistance 2
506.67
Resistance 1
500.73
Pivot
492.77
Support 1
486.83
Support 2
478.87
Support 3
464.97
Support 4
451.07
Support 5
437.17
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 32.34% | 32.36% | 32.39% | 32.42% | 32.42% | 32.45% |
| 37.91% | 37.87% | 37.97% | 38.02% | 39.15% | 40.49% |
| 1.70% | 1.96% | 2.01% | 2.07% | 1.53% | 1.37% |
| 6.02% | 5.87% | 5.77% | 5.85% | 4.91% | 3.84% |
| 22.03% | 21.94% | 21.86% | 21.64% | 21.99% | 21.85% |
Bulk & block deals
Name
Icici Prudential Mutual Fund
Polar Capital Funds Plc-Healthcare Opportunities Fund
Invesco Mutual Fund
Marwadi Chandarana Intermediaries Brokers Private Limited
Allianz Global Investors Gmbh Acting On Behalf Of Allianz Eee Fonds
Hyperion Investments Pte. Ltd.
Claymore Investments (Mauritius) Pte.ltd.
Marwadi Chandarana Intermediaries Brokers Private Limited
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs (Singapore) Pte - Odi
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 12 Aug 2026 | Purchase | 311.21 Cr | ₹501 | 62.12 L | Bulk | 1.959401 | NSE |
| 12 Aug 2026 | Purchase | 181.68 Cr | ₹501 | 36.26 L | Bulk | 1.143883 | NSE |
| 12 Aug 2026 | Purchase | 179.93 Cr | ₹504.64 | 35.65 L | Bulk | 1.124652 | NSE |
| 12 Aug 2026 | Purchase | 98.47 Cr | ₹502.46 | 19.60 L | Bulk | 0.618185 | NSE |
| 12 Aug 2026 | Purchase | 88.78 Cr | ₹501 | 17.72 L | Bulk | 0.558984 | NSE |
| 12 Aug 2026 | Sell | 1,210.49 Cr | ₹501.03 | 2.42 Cr | Bulk | 7.620821 | NSE |
| 12 Aug 2026 | Sell | 797.45 Cr | ₹501.54 | 1.59 Cr | Bulk | 5.015358 | NSE |
| 12 Aug 2026 | Sell | 33.25 Cr | ₹510.96 | 6.51 L | Bulk | 0.205285 | NSE |
| 02 Sep 2025 | Purchase | 71.65 Cr | ₹433.25 | 16.54 L | Bulk | 0.521637 | NSE |
| 02 Sep 2025 | Sell | 71.65 Cr | ₹433.25 | 16.54 L | Bulk | 0.521637 | NSE |
Insider trading & SAST
Client name
Claymore Investments (Mauritius) Pte Ltd
Icici Prudential Mutual Fund
Invesco Mutual Fund
Hyperion Investments Pte Ltd
Dr. Anosh Agarwal
Dr Athiya Agarwal
Dr Athiya Agarwal
Dr. Athiya Agarwal
Dr. Athiya Agarwal
Dr Anosh Agarwal
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 Aug 2026 | Other | Disposal | 5.02 | 15.04 | 0 | — | 1.59 Cr | 12 Aug 2026 | Market | 4,76,71,770 | SAST | 29(2) | — |
| 26 Aug 2026 | Other | Acquisition | 5.36 | 5.36 | 0 | — | 1.70 Cr | 12 Aug 2026 | Market | 1,69,99,999 | SAST | 29(1) | — |
| 26 Aug 2026 | Other | Acquisition | 2.18 | 5.21 | 0 | — | 69.38 L | 12 Aug 2026 | Market | 1,65,25,136 | SAST | 29(1) | — |
| 26 Aug 2026 | Other | Disposal | 7.62 | 15.47 | 0 | — | 2.42 Cr | 12 Aug 2026 | Market | 4,90,33,988 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Disposal | 0.67 | 4.69 | 0 | — | 21.15 L | 04 Mar 2026 | Off Market / Inter se transfer | 1,48,57,920 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.45 | 4.45 | 0 | — | 14.42 L | 19 Mar 2026 | Off Market / Inter se transfer | 1,41,03,543 | SAST | 29(2) | — |
| 13 Apr 2026 | Other | Acquisition | 0.67 | — | 0 | — | 21.15 L | 04 Mar 2026 | - | — | SAST | 10(6) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.46 | — | 0 | — | 14.42 L | 13 Mar 2026 | — | — | SAST | 10(5) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.67 | 4 | 0 | — | 21.15 L | 04 Mar 2026 | Off Market / Inter se transfer | 1,26,61,975 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Disposal | 0.45 | 4.23 | 0 | — | 14.42 L | 19 Mar 2026 | Off Market / Inter se transfer | 1,34,16,352 | SAST | 29(2) | — |
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Dr. Agarwal's Health Care provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories,
Corporate Actions
Date
Type
Details
Company details
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Dr. Agarwal's Health Care Share Price
502.10+7.30 (+1.48%)
+9.03% past 1 Year
News
Dr. Agarwal's Health Care plans Delhi NCR expansion over next 2 to 3 years
Equity
AGARWALEYE
Dr Agarwal's Health Care to host analyst and investor meet on 16 September
Equity
AGARWALEYE
Dr. Agarwal Health Care reports higher Q1 EBITDA and margin
Equity
AGARWALEYE
Dr. Agarwal'S Health Care posts strong Q1 revenue growth on robust operations
Equity
AGARWALEYE
Dr. Agarwal's Health Care reports higher Q1 net profit year on year
Equity
AGARWALEYE
Dr. Agarwal'S Health Care to host Q1 FY27 earnings call on August 4
Equity
AGARWALEYE
Dr. Agarwal's Health Care’s arm invests $2,00,000 in Orbit Health Care ETH
Equity
AGARWALEYE
Dr. Agarwal's Health - Quaterly Results
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 10.60 Crores, in the March 2026 quarter
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about updates
Equity
AGARWALEYE
Dr. Agarwal's Health Care Terminates Idearx Associate Status Effective March 30, 2026, Retains 14.54% Stake.
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosures
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Morgan Stanley Maintains Overweight on Dr Agarwal’s Health Care with Rs 596 Target Price.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3 FY26 EBITDA Rises 27% YoY to Rs 140 Cr, Margin Expands to 27.17%.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3FY26 Net Profit Rises 51% YoY to Rs 33.70 Crores on 23% Revenue Growth.
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 14.06 Crores, in the December 2025 quarter
Equity
AGARWALEYE
Dr Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about investor presentation
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 4.68 Crores, in the September 2025 quarter
Equity
AGARWALEYE